Genencor Licenses the ERGO™ Genomics Platform for Microbial Production of Enzymes and other Bioproducts’
CHICAGO–(BUSINESS WIRE)–Integrated Genomics announced today that Genencor, the biotechnology division of Danisco A/S that develops innovative enzymes and bio-products, has licensed the ERGO™ bioinformatics software system to characterize and optimize microbial products used in reducing the environmental impact of the cleaning, textiles, fuel and chemical industries. ERGO is a powerful software platform for analyzing genome sequences and performing gene annotations, metabolic reconstructions, and other gene analyses and comparisons.
Optimized for analysis of microorganisms, ERGO integrates biological data from genomics, biochemistry, gene expression studies, genetics and literature. Reaching beyond conventional systems for functional analysis of DNA sequences, Integrated Genomics’ platform combines pattern-based analysis with comparative genomics and enables visualization of genes in the contexts of regulation, gene expression data, phylogeny, chromosomal neighborhoods and identification of natural gene fusions. ERGO contains more than 1145 genomes at various stages of completion, as well as the largest available collection of networked cellular pathways.
About Integrated Genomics
Integrated Genomics (www.integratedgenomics.com) is a provider of bioinformatics products and services for the life science industry, with a recent focus on the use of in silico strategies for comparative genomics. The company’s expertise in microbial genomics includes genome sequencing, genome analysis and custom bioinformatics. IG has developed and distributed ERGO, the most advanced and comprehensive bioinformatics suite for microbial genomics on the market. ERGO contains the largest available integration of microbial genome data, including genome-derived metabolic reconstructions and representing the chemical reaction networks of metabolic pathways.
